- Home
- CMBM vs LVTX Comparison
CMBM vs LVTX Comparison
Compare CMBM & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- LVTX
- Stock Information
- Founded
- CMBM 2011
- LVTX 2016
- Country
- CMBM United States
- LVTX Netherlands
- Employees
- CMBM N/A
- LVTX N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- LVTX Health Care
- Exchange
- CMBM Nasdaq
- LVTX Nasdaq
- Market Cap
- CMBM 18.6M
- LVTX 41.3M
- IPO Year
- CMBM 2019
- LVTX 2021
- Fundamental
- Price
- CMBM $0.74
- LVTX $1.50
- Analyst Decision
- CMBM Buy
- LVTX Hold
- Analyst Count
- CMBM 1
- LVTX 4
- Target Price
- CMBM $3.00
- LVTX $1.58
- AVG Volume (30 Days)
- CMBM 176.1K
- LVTX 99.9K
- Earning Date
- CMBM 11-06-2025
- LVTX 08-13-2025
- Dividend Yield
- CMBM N/A
- LVTX N/A
- EPS Growth
- CMBM N/A
- LVTX N/A
- EPS
- CMBM N/A
- LVTX N/A
- Revenue
- CMBM $172,215,000.00
- LVTX $4,990,000.00
- Revenue This Year
- CMBM N/A
- LVTX N/A
- Revenue Next Year
- CMBM $17.73
- LVTX N/A
- P/E Ratio
- CMBM N/A
- LVTX N/A
- Revenue Growth
- CMBM N/A
- LVTX N/A
- 52 Week Low
- CMBM $0.23
- LVTX $0.85
- 52 Week High
- CMBM $2.08
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- CMBM 51.32
- LVTX 43.85
- Support Level
- CMBM $0.62
- LVTX $1.53
- Resistance Level
- CMBM $0.78
- LVTX $1.57
- Average True Range (ATR)
- CMBM 0.05
- LVTX 0.03
- MACD
- CMBM 0.01
- LVTX -0.01
- Stochastic Oscillator
- CMBM 62.42
- LVTX 10.10
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.